WNT signaling in adult cardiac hypertrophy and remodeling: Lessons learned from cardiac development

Circulation Research

Volumn 107, Issue 10, 2010, Pages 1198-1208

  Bergmann, Martin W ^a,b  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b DEPARTMENT OF CARDIOLOGY   (Germany)

Author keywords

catenin; angiogenesis; heart failure; progenitor cells; WNT

Indexed keywords

BETA CATENIN; CARRIER PROTEIN; SECRETED FRIZZLED RELATED PROTEIN 1; SECRETED FRIZZLED RELATED PROTEIN 3; SECRETED FRIZZLED RELATED PROTEIN 4; UNCLASSIFIED DRUG; WNT PROTEIN;

CONGESTIVE CARDIOMYOPATHY; GENETIC TRANSCRIPTION; HEART DEVELOPMENT; HEART VENTRICLE HYPERTROPHY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BETA CATENIN; CARDIOMEGALY; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; FRIZZLED RECEPTORS; HEART; HEART VENTRICLES; HUMANS; MORPHOGENESIS; MYOCARDIUM; PHOSPHOPROTEINS; SIGNAL TRANSDUCTION; STEM CELLS; VENTRICULAR REMODELING; WNT PROTEINS;

EID: 78549292104     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.110.223768     Document Type: Review

References (68)

1. Oka T, Xu J, Molkentin JD. Re-employment of developmental transcriptionfactors in adult heart disease. Semin Cell Dev Biol. 2007;18:117-131.
2. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabe-Heider F, Walsh S, Zupicich J, Alkass K, Buchholz BA, Druid H, Jovinge S, FrisenJ. Evidence for cardiomyocyte renewal in humans. Science. 2009;324:98-102.
3. Domian IJ, Chiravuri M, van der Meer P, Feinberg AW, Shi X, Shao Y, Wu SM, Parker KK, Chien KR. Generation of functional ventricular heartmuscle from mouse ventricular progenitor cells. Science. 2009;326:426-429.
4. Ueno S, Weidinger G, Osugi T, Kohn AD, Golob JL, Pabon L, ReineckeH, Moon RT, Murry CE. Biphasic role for Wnt/beta-catenin signaling incardiac specification in zebrafish and embryonic stem cells. Proc NatlAcad Sci USA. 2007;104:9685-9690.
5. Naito AT, Shiojima I, Akazawa H, Hidaka K, Morisaki T, Kikuchi A, Komuro I. Developmental stage-specific biphasic roles of Wnt/betacateninsignaling in cardiomyogenesis and hematopoiesis. Proc Natl AcadSci USA. 2006;103:19812-19817.
6. Malekar P, Hagenmueller M, Anyanwu A, Buss S, Streit MR, Weiss CS, Wolf D, Riffel J, Bauer A, Katus HA, Hardt SE. Wnt signaling is criticalfor maladaptive cardiac hypertrophy and accelerates myocardialremodeling. Hypertension. 2010;55:939-945.
7. Barandon L, Couffinhal T, Ezan J, Dufourcq P, Costet P, Alzieu P, Leroux L, Moreau C, Dare D, Duplaa C. Reduction of infarct size andprevention of cardiac rupture in transgenic mice overexpressing FrzA.Circulation. 2003;108:2282-2289.
8. Alfaro MP, Pagni M, Vincent A, Atkinson J, Hill MF, Cates J, DavidsonJM, Rottman J, Lee E, Young PP. The Wnt modulator sFRP2 enhancesmesenchymal stem cell engraftment, granulation tissue formation andmyocardial repair. Proc Natl Acad Sci USA. 2008;105:18366-18371.
9. Lindsley RC, Gill JG, Murphy TL, Langer EM, Cai M, Mashayekhi M, Wang W, Niwa N, Nerbonne JM, Kyba M, Murphy KM. Mesp1 coordinatelyregulates cardiovascular fate restriction and epithelialmesenchymaltransition in differentiating ESCs. Cell Stem Cell. 2008;3:55-68.
10. Bondue A, Lapouge G, Paulissen C, Semeraro C, Iacovino M, Kyba M, Blanpain C. Mesp1 acts as a master regulator of multipotent cardiovascularprogenitor specification. Cell Stem Cell. 2008;3:69-84.
11. David R, Brenner C, Stieber J, Schwarz F, Brunner S, Vollmer M, Mentele E, Muller-Hocker J, Kitajima S, Lickert H, Rupp R, Franz WM.MesP1 drives vertebrate cardiovascular differentiation through Dkk-1-mediated blockade of Wnt-signalling. Nat Cell Biol. 2008;10:338-345.
12. Blin G, Nury D, Stefanovic S, Neri T, Guillevic O, Brinon B, Bellamy V, Rucker-Martin C, Barbry P, Bel A, Bruneval P, Cowan C, Pouly J, Mitalipov S, Gouadon E, Binder P, Hagege A, Desnos M, Renaud JF, Menasche P, Puceat M. A purified population of multipotent cardiovascularprogenitors derived from primate pluripotent stem cells engrafts inpostmyocardial infarcted nonhuman primates. J Clin Invest. 2010;120:1125-1139.
13. Zhu W, Shiojima I, Ito Y, Li Z, Ikeda H, Yoshida M, Naito AT, Nishi J, Ueno H, Umezawa A, Minamino T, Nagai T, Kikuchi A, Asashima M, Komuro I. IGFBP-4 is an inhibitor of canonical Wnt signalling requiredfor cardiogenesis. Nature. 2008;454:345-349.
14. Baurand A, Zelarayan L, Betney R, Gehrke C, Dunger S, Noack C, Busjahn A, Huelsken J, Taketo MM, Birchmeier W, Dietz R, BergmannMW. Beta-catenin downregulation is required for adaptive cardiacremodeling. Circ Res. 2007;100:1353-1362.
15. Santini MP, Tsao L, Monassier L, Theodoropoulos C, Carter J, Lara-Pezzi E, Slonimsky E, Salimova E, Delafontaine P, Song YH, Bergmann M, Freund C, Suzuki K, Rosenthal N. Enhancing repair of themammalian heart. Circ Res. 2007;100:1732-1740.
16. Gessert S, Kuhl M. The multiple phases and faces of Wnt signalingduring cardiac differentiation and development. Circ Res. 2010;107:186-199.
17. Olson EN. Development. The path to the heart and the road not taken. Science. 2001;291:2327-2328.
18. Klaus A, Saga Y, Taketo MM, Tzahor E, Birchmeier W. Distinct roles ofWnt/beta-catenin and BMP signaling during early cardiogenesis. ProcNatl Acad Sci USA. 2007.
19. Gessert S, Kuhl M. Comparative gene expression analysis and fatemapping studies suggest an early segregation of cardiogenic lineages inxenopus laevis. Dev Biol. 2009;334:395-408.
20. Lin L, Cui L, Zhou W, Dufort D, Zhang X, Cai CL, Bu L, Yang L, MartinJ, Kemler R, Rosenfeld MG, Chen J, Evans SM. Beta-catenin directlyregulates islet1 expression in cardiovascular progenitors and is requiredfor multiple aspects of cardiogenesis. Proc Natl Acad Sci USA. 2007;104:9313-9318.
21. Kwon C, Qian L, Cheng P, Nigam V, Arnold J, Srivastava D. A regulatorypathway involving Notch1/beta-catenin/Isl1 determines cardiacprogenitor cell fate. Nat Cell Biol. 2009;11:951-957.
22. Qyang Y, Martin-Puig S, Chiravuri M, Chen S, Xu H, Bu L, Jiang X, LinL, Granger A, Moretti A, Caron L, Wu X, Clarke J, Taketo MM, Laugwitz KL, Moon RT, Gruber P, Evans SM, Ding S, Chien KR. Therenewal and differentiation of Isl1- cardiovascular progenitors are controlledby a Wnt/beta-catenin pathway. Cell Stem Cell. 2007;1:165-179.
23. Singh AM, Li F-Q, Hamazaki T, Kasahara H, Takemaru K-I, Terada N.Chibby, an antagonist of the Wnt/{beta}-catenin pathway, facilitates cardiomyocytedifferentiation of murine embryonic stem cells. Circulation. 2007;115:617-626.
24. Buckingham M, Meilhac S, Zaffran S. Building the mammalian heartfrom two sources of myocardial cells. Nat Rev. 2005;6:826-835.
25. Prall OW, Menon MK, Solloway MJ, Watanabe Y, Zaffran S, Bajolle F, Biben C, McBride JJ, Robertson BR, Chaulet H, Stennard FA, Wise N, Schaft D, Wolstein O, Furtado MB, Shiratori H, Chien KR, Hamada H, Black BL, Saga Y, Robertson EJ, Buckingham ME, Harvey RP. AnNkx2-5/Bmp2/Smad1 negative feedback loop controls heart progenitorspecification and proliferation. Cell. 2007;128:947-959.
26. Zeisberg EM, Ma Q, Juraszek AL, Moses K, Schwartz RJ, Izumo S, PuWT. Morphogenesis of the right ventricle requires myocardial expressionof Gata4. J Clin Invest. 2005;115:1522-1531.
27. Bruneau BG, Bao ZZ, Fatkin D, Xavier-Neto J, Georgakopoulos D, Maguire CT, Berul CI, Kass DA, Kuroski-de Bold ML, de Bold AJ, Conner DA, Rosenthal N, Cepko CL, Seidman CE, Seidman JG. Cardiomyopathyin Irx4-deficient mice is preceded by abnormal ventriculargene expression. Mol Cell Biol. 2001;21:1730-1736.
28. Sanchez A, Jones WK, Gulick J, Doetschman T, Robbins J. Myosinheavy chain gene expression in mouse embryoid bodies. An in vitrodevelopmental study. J Biol Chem. 1991;266:22419-22426.
29. Lyons GE, Schiaffino S, Sassoon D, Barton P, Buckingham M. Developmentalregulation of myosin gene expression in mouse cardiac muscle. J Cell Biol. 1990;111:2427-2436. (Pubitemid 120014527)
30. Jones WK, Grupp IL, Doetschman T, Grupp G, Osinska H, Hewett TE, Boivin G, Gulick J, Ng WA, Robbins J. Ablation of the murine alphamyosin heavy chain gene leads to dosage effects and functional deficits inthe heart. J Clin Invest. 1996;98:1906-1917.
31. Zelarayán LC, Noack C, Sekkali B, Kmecova J, Gehrke C, Renger A, Zafiriou MP, van der Nagel R, Dietz R, de Windt LJ, Balligand JL, Bergmann MW. Beta-catenin downregulation attenuates ischemic cardiacremodeling through enhanced resident precursor cell differentiation. ProcNatl Acad Sci USA. 2008;105:19762-19767.
32. Grigoryan T, Wend P, Klaus A, Birchmeier W. Deciphering the functionof canonical Wnt signals in development and disease: conditional lossandgain-of-function mutations of beta-catenin in mice. Genes Dev. 2008;22:2308-2341.
33. Schumann H, Holtz J, Zerkowski HR, Hatzfeld M. Expression of secretedfrizzled related proteins 3 and 4 in human ventricular myocardium correlateswith apoptosis related gene expression. Cardiovasc Res. 2000;45:720-728.
34. Dufourcq P, Couffinhal T, Ezan J, Barandon L, Moreau C, Daret D, Duplaa C. FrzA, a secreted frizzled related protein, induced angiogenicresponse. Circulation. 2002;106:3097-3103.
35. Mirotsou M, Zhang Z, Deb A, Zhang L, Gnecchi M, Noiseux N, Mu H, Pachori A, Dzau V. Secreted frizzled related protein 2 (sFRP2) is the keyAkt-mesenchymal stem cell-released paracrine factor mediating myocardialsurvival and repair. Proc Natl Acad Sci USA. 2007;104:1643-1648.
36. Zhang Z, Deb A, Pachori A, He W, Guo J, Pratt R, Dzau VJ. Secretedfrizzled related protein 2 protects cells from apoptosis by blocking theeffect of canonical Wnt3a. J Mol Cell Cardiol. 2009;46:370-377.
37. Kobayashi K, Luo M, Zhang Y, Wilkes DC, Ge G, Grieskamp T, YamadaC, Liu TC, Huang G, Basson CT, Kispert A, Greenspan DS, Sato TN.Secreted frizzled-related protein 2 is a procollagen c proteinase enhancerwith a role in fibrosis associated with myocardial infarction. Nat CellBiol. 2009;11:46-55.
38. Barandon L, Dufourcq P, Costet P, Moreau C, Allieres C, Daret D, DosSantos P, Daniel Lamaziere JM, Couffinhal T, Duplaa C. Involvement offrza/sFRP-1 and the Wnt/frizzled pathway in ischemic preconditioning. Circ Res. 2005;96:1299-1306.
39. Barcelos LS, Duplaa C, Krankel N, Graiani G, Invernici G, Katare R, Siragusa M, Meloni M, Campesi I, Monica M, Simm A, Campagnolo P, Mangialardi G, Stevanato L, Alessandri G, Emanueli C, Madeddu P.Human CD133- progenitor cells promote the healing of diabetic ischemiculcers by paracrine stimulation of angiogenesis and activation of Wntsignaling. Circ Res. 2009;104:1095-1102.
40. Ezan J, Leroux L, Barandon L, Dufourcq P, Jaspard B, Moreau C, Allieres C, Daret D, Couffinhal T, Duplaa C. FrzA/sFRP-1, a secretedantagonist of the Wnt-frizzled pathway, controls vascular cell proliferationin vitro and in vivo. Cardiovasc Res. 2004;63:731-738.
41. Wang X, Xiao Y, Mou Y, Zhao Y, Blankesteijn WM, Hall JL. A role forthe {beta}-catenin/T-cell factor signaling cascade in vascular remodeling. Circ Res. 2002;90:340-347.
42. van de Schans VA, Smits JF, Blankesteijn WM. The Wnt/frizzledpathway in cardiovascular development and disease: friend or foe? EurJ Pharmacol. 2008;585:338-345.
43. van Empel VPM, De Windt LJ. Myocyte hypertrophy and apoptosis: abalancing act. Cardiovasc Res. 2004;63:487-499.
44. Zelarayan L, Gehrke C, Bergmann MW. Role of beta-catenin in adultcardiac remodeling. Cell Cycle. 2007;6:2120-2126.
45. van Gijn ME, Snel F, Cleutjens JP, Smits JF, Blankesteijn WM. Overexpressionof components of the Frizzled-Dishevelled cascade results inapoptotic cell death, mediated by beta-catenin. Exp Cell Res. 2001;265:46-53.
46. Rao TP, Kuhl M. An updated overview on Wnt signaling pathways: aprelude for more. Circ Res. 2010;106:1798-1806.
47. Backs J, Song K, Bezprozvannaya S, Chang S, Olson EN. CaM kinase IIselectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J Clin Invest. 2006;116:1853-1864.
48. Zelarayan LC, Noack C, Zafiriou MP, Renger A, Bergmann MW. Wntsignaling molecules in left ventricular remodeling: focus on dishevelled 1.Hypertension. 2010;55:852-854.
49. Laeremans H, Rensen SS, Ottenheijm HC, Smits JF, Blankesteijn WM.Wnt/frizzled signalling modulates the migration and differentiation ofimmortalized cardiac fibroblasts. Cardiovasc Res. 2010;87:514-523.
50. van de Schans VA, van den Borne SW, Strzelecka AE, Janssen BJ, vander Velden JL, Langen RC, Wynshaw-Boris A, Smits JF, BlankesteijnWM. Interruption of Wnt signaling attenuates the onset of pressureoverload-induced cardiac hypertrophy. Hypertension. 2007;49:473-480.
51. Passier R, Zeng H, Frey N, Naya FJ, Nicol RL, McKinsey TA, OverbeekP, Richardson JA, Grant SR, Olson EN. CaM kinase signaling inducescardiac hypertrophy and activates the MEF2 transcription factor in vivo. J Clin Invest. 2000;105:1395-1406.
52. Moeller H, Jenny A, Schaeffer HJ, Schwarz-Romond T, Mlodzik M, Hammerschmidt M, Birchmeier W. Diversin regulates heart formationand gastrulation movements in development. Proc Natl Acad Sci USA.2006;103:15900- 15905.
53. Force T, Woulfe K, Koch WJ, Kerkela R. Molecular scaffolds regulatebidirectional crosstalk between Wnt and classical seven- transmembranedomainreceptor signaling pathways. Sci STKE. 2007;2007:pe41.
54. Syed F, Odley A, Hahn HS, Brunskill EW, Lynch RA, Marreez Y, SanbeA, Robbins J, Dorn GW II. Physiological growth synergizes with pathologicalgenes in experimental cardiomyopathy. Circ Res. 2004;95:1200-1206.
55. Zhou J, Qu J, Yi XP, Graber K, Huber L, Wang X, Gerdes AM, Li F.Up-regulation of {gamma}-catenin compensates for the loss of {beta}-catenin in adult cardiac myocytes. Am J Physiol Heart Circ Physiol.2007;292:H270-H276.
56. Chen X, Shevtsov SP, Hsich E, Cui L, Haq S, Aronovitz M, Kerkela R, Molkentin JD, Liao R, Salomon RN, Patten R, Force T. The {beta}-catenin/T-cell factor/lymphocyte enhancer factor signaling pathway isrequired for normal and stress-induced cardiac hypertrophy. Mol CellBiol. 2006;26:4462-4473.
57. Logan CY, Nusse R. The Wnt signaling pathway in development anddisease. Annu Rev Cell Dev Biol. 2004;20:781-810.
58. Ziebart T, Yoon CH, Trepels T, Wietelmann A, Braun T, Kiessling F, Stein S, Grez M, Ihling C, Muhly-Reinholz M, Carmona G, Urbich C, Zeiher AM, Dimmeler S. Sustained persistence of transplanted proangiogeniccells contributes to neovascularization and cardiac function afterischemia. Circ Res. 2008;103:1327-1334.
59. Aicher A, Kollet O, Heeschen C, Liebner S, Urbich C, Ihling C, OrlandiA, Lapidot T, Zeiher AM, Dimmeler S. The Wnt antagonist dickkopf-1mobilizes vasculogenic progenitor cells via activation of the bone marrowendosteal stem cell niche. Circ Res. 2008;103:796-803.
60. Misfeldt AM, Boyle SC, Tompkins KL, Bautch VL, Labosky PA, Baldwin HS. Endocardial cells are a distinct endothelial lineage derivedfrom Flk1- multipotent cardiovascular progenitors. Dev Biol. 2009;333:78-89.
61. Couffinhal T, Dufourcq P, Duplaa C. Beta-catenin nuclear activation:common pathway between Wnt and growth factor signaling in vascularsmooth muscle cell proliferation? Circ Res. 2006;99:1287-1289.
62. Stamm C, Kleine H-D, Choi Y-H, Dunkelmann S, Lauffs J-A, LorenzenB, David A, Liebold A, Nienaber C, Zurakowski D, Freund M, SteinhoffG. Intramyocardial delivery of CD133- bone marrow cells and coronaryartery bypass grafting for chronic ischemic heart disease: safety andefficacy studies. J Thorac Cardiovasc Surg. 2007;133:717-725.
63. Scheller M, Huelsken J, Rosenbauer F, Taketo MM, Birchmeier W, Tenen DG, Leutz A. Hematopoietic stem cell and multilineage defectsgenerated by constitutive-catenin activation. Nat Immunol. 2006;7:1037-1047.
64. Kaczynski J, Cook T, Urrutia R. Sp1-and Kruppel-like transcriptionfactors. Genome Biol. 2003;4:206.
65. Haldar SM, Ibrahim OA, Jain MK. Kruppel-like factors (KLFs) in musclebiology. J Mol Cell Cardiol. 2007;43:1-10.
66. Fisch S, Gray S, Heymans S, Haldar SM, Wang B, Pfister O, Cui L, Kumar A, Lin Z, Sen-Banerjee S, Das H, Petersen CA, Mende U, Burleigh BA, Zhu Y, Pinto YM, Liao R, Jain MK. Kruppel-like factor 15is a regulator of cardiomyocyte hypertrophy. Proc Natl Acad Sci USA.2007;104:7074-7079. (Pubitemid 47186011)
67. Wang B, Haldar SM, Lu Y, Ibrahim OA, Fisch S, Gray S, Leask A, JainMK. The Kruppel-like factor KLF15 inhibits connective tissue growthfactor (CTGF) expression in cardiac fibroblasts. J Mol Cell Cardiol.2008;45:193-197.
68. Bu L, Jiang X, Martin-Puig S, Caron L, Zhu S, Shao Y, Roberts DJ, HuangPL, Domian IJ, Chien KR. Human Isl1 heart progenitors generate diversemultipotent cardiovascular cell lineages. Nature. 2009;460:113-117.